Regeneron Pharmaceuticals, Inc.
METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR

Last updated:

Abstract:

The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody.

Status:
Application
Type:

Utility

Filling date:

10 May 2019

Issue date:

14 Nov 2019